The Oncology Institute, Inc. (STLN) — Long-term Investment Intensity
The Oncology Institute, Inc. (STLN) has a Long-term Investment Intensity of 22.3% as of December 2022. Long-term investments of $58.35 Million represent 22.3% of total assets of $261.67 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See working capital to net assets of The Oncology Institute, Inc. to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
The Oncology Institute, Inc. Long-term Investment Intensity (2022–2022)
This chart shows how The Oncology Institute, Inc.'s Long-term Investment Intensity has evolved across 1 annual periods from 2022 to 2022. As of December 2022, the intensity stands at 22.3%, reflecting long-term investments of $58.35 Million against total assets of $261.67 Million USD. See The Oncology Institute, Inc. liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Annual Long-term Investment Intensity for The Oncology Institute, Inc. (2022–2022)
The table below presents the year-by-year Long-term Investment Intensity for The Oncology Institute, Inc. from 2022 to 2022, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see STLN total asset value.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2022 | 22.3% | $58.35 Million | $261.67 Million | — |